Cavco Industries (NASDAQ:CVCO) reported quarterly earnings of $6.66 per share which beat the analyst consensus estimate of $5.79 by 15.03 percent. This is a 24.72 percent increase over earnings of $5.34 per share from the same period last year. The company reported quarterly sales of $500.60 million which missed the analyst consensus estimate of $525.91 million by 4.81 percent. This is a 15.96 percent increase over sales of $431.71 million the same period last year.
Jefferies Downgrades Vertex Pharmaceuticals to Hold, Announces $340 Price Target
Jefferies analyst Michael Yee downgrades Vertex Pharmaceuticals (NASDAQ:VRTX) from Buy to Hold and announces $340 price target.
